UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing

Science translational medicine, 2012-09, Vol.4 (152), p.152ra129

2012

Link zum Volltext

Verfügbarkeit prüfen

Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma

World journal of gastroenterology : WJG, 2016-03, Vol.22 (12), p.3404-3411

2016

Link zum Volltext

Verfügbarkeit prüfen

Knee Pain in a 9-year-old Girl

Clinical orthopaedics and related research, 2013-10, Vol.471 (10), p.3367-3371

2013

Link zum Volltext

Verfügbarkeit prüfen

Epiphyseal lesion of the humerus in a child

Skeletal radiology, 2013-07, Vol.42 (7), p.1001-1002

2013

Link zum Volltext

Verfügbarkeit prüfen

Epiphyseal lesion of the humerus in a child

Skeletal radiology, 2013-07, Vol.42 (7), p.1021-1023

2013

Link zum Volltext

Verfügbarkeit prüfen

Proximal tibial pain in a child

Skeletal radiology, 2013-09, Vol.42 (9), p.1297-1299

2013

Link zum Volltext

Verfügbarkeit prüfen

Proximal tibial pain in a child

Skeletal radiology, 2013-09, Vol.42 (9), p.1333-1336

2013

Link zum Volltext

Verfügbarkeit prüfen

Acute monoblastic leukemia with abnormal granules and disseminated intravascular coagulation: Diagnostic pitfalls

American journal of hematology, 2009-11, Vol.84 (11), p.773-775

2009

Link zum Volltext

Verfügbarkeit prüfen

Epiphyseal lesion of the humerus in a child. Solitary epiphyseal enchondroma of the humeral greater tuberosity

Skeletal radiology, 2013-07, Vol.42 (7), p.1001-1003

2013

Link zum Volltext

Verfügbarkeit prüfen

Acute monoblastic leukemia with abnormal granules and disseminated intravascular coagulation: diagnostic pitfalls

American journal of hematology, 2009, Vol.84 (11), p.773-775

2009

Link zum Volltext

Verfügbarkeit prüfen

Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer

Cancer, 2021-10, Vol.127 (19), p.3622-3630

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of ESR1 variants in breast cancer

Breast cancer research and treatment, 2022-11, Vol.196 (2), p.279-289

2022

Link zum Volltext

Verfügbarkeit prüfen

Pre-clinical analysis of the CDK4/6 inhibitor palbociclib in HER2-positive breast cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12520-e12520

2017

Link zum Volltext

Verfügbarkeit prüfen

Fourteen Day In Vivo Testing of a Compliant Thoracic Artificial Lung

ASAIO journal (1992), 2017-09, Vol.63 (5), p.644-649

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of trophoblast cell surface antigen 2 (Trop-2) positive triple negative breast cancer (TNBC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14651-e14651

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-19-20: Safety of palbociclib in African American women with hormone receptor positive HER2 negative advanced breast cancer and benign ethnic neutropenia: PALINA study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-19-20

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD3-08: Tucatinib vs placebo in combination with trastuzumab and capecitabine for patients with locally advanced unresectable or HER2-positive metastatic breast cancer (HER2CLIMB): Outcomes by hormone receptor status

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD3-08-PD3-08

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract B90: PFK-158 is a first-in-human inhibitor of PFKFB3 that selectively suppresses glucose metabolism of cancer cells and inhibits the immunosuppressive Th17 cells and MDSCs in advanced cancer patients

Cancer research (Chicago, Ill.), 2016-12, Vol.76 (24_Supplement), p.B90-B90

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT206: PFK-158, first-in-man and first-in-class inhibitor of PFKFB3/ glycolysis: A phase I, dose escalation, multi-center study in patients with advanced solid malignancies

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.CT206-CT206

2015

Link zum Volltext

Verfügbarkeit prüfen

A phase I, dose-escalation, multi-center study of PFK-158 in patients with advanced solid malignancies explores a first-in-man inhbibitor of glycolysis

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS2606-TPS2606

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)
Berichte
(1)

Sprache

Englisch
(29)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(12)
Humans
(10)
Female
(6)
Medicine
(6)
Medicine & Public Health
(6)
Orthopedics
(5)
Imaging
(4)
Male
(4)
Medical Centers
(4)
Medical Colleges
(4)
Nuclear Medicine
(4)
Pathology
(4)
Radiology
(4)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Breast Cancer
(3)
Oncology
(3)
Adult
(2)
Aged
(2)
Ammonia
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing

Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma

Knee Pain in a 9-year-old Girl

Epiphyseal lesion of the humerus in a child

Epiphyseal lesion of the humerus in a child

Proximal tibial pain in a child

Proximal tibial pain in a child

Acute monoblastic leukemia with abnormal granules and disseminated intravascular coagulation: Diagnostic pitfalls

Epiphyseal lesion of the humerus in a child. Solitary epiphyseal enchondroma of the humeral greater tuberosity

Acute monoblastic leukemia with abnormal granules and disseminated intravascular coagulation: diagnostic pitfalls

Engineering and two-stage evolution of a lignocellulosic hydrolysate-tolerant Saccharomyces cerevisiae strain for anaerobic fermentation of xylose from AFEX pretreated corn stover

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study

Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer

Molecular characterization of ESR1 variants in breast cancer

Pre-clinical analysis of the CDK4/6 inhibitor palbociclib in HER2-positive breast cancer

Fourteen Day In Vivo Testing of a Compliant Thoracic Artificial Lung

Molecular characterization of trophoblast cell surface antigen 2 (Trop-2) positive triple negative breast cancer (TNBC)

Abstract PD9-02: Peripheral immune subsets and circulating tumor DNA (ctDNA) in patients (pts) with residual triple negative breast cancer (TNBC) treated with adjuvant immunotherapy and/or chemotherapy (chemo): The OXEL study

Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study

Abstract P1-19-20: Safety of palbociclib in African American women with hormone receptor positive HER2 negative advanced breast cancer and benign ethnic neutropenia: PALINA study

Abstract PD3-08: Tucatinib vs placebo in combination with trastuzumab and capecitabine for patients with locally advanced unresectable or HER2-positive metastatic breast cancer (HER2CLIMB): Outcomes by hormone receptor status

Abstract B90: PFK-158 is a first-in-human inhibitor of PFKFB3 that selectively suppresses glucose metabolism of cancer cells and inhibits the immunosuppressive Th17 cells and MDSCs in advanced cancer patients

Abstract CT206: PFK-158, first-in-man and first-in-class inhibitor of PFKFB3/ glycolysis: A phase I, dose escalation, multi-center study in patients with advanced solid malignancies

A phase I, dose-escalation, multi-center study of PFK-158 in patients with advanced solid malignancies explores a first-in-man inhbibitor of glycolysis

Suchergebnisse filtern